1. Home
  2. COHU vs PGEN Comparison

COHU vs PGEN Comparison

Compare COHU & PGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Cohu Inc.

COHU

Cohu Inc.

HOLD

Current Price

$47.68

Market Cap

1.9B

Sector

Industrials

ML Signal

HOLD

Logo Precigen Inc.

PGEN

Precigen Inc.

HOLD

Current Price

$5.54

Market Cap

1.6B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
COHU
PGEN
Founded
1947
1998
Country
United States
United States
Employees
N/A
N/A
Industry
Electrical Products
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.9B
1.6B
IPO Year
1994
2013

Fundamental Metrics

Financial Performance
Metric
COHU
PGEN
Price
$47.68
$5.54
Analyst Decision
Strong Buy
Buy
Analyst Count
6
5
Target Price
$40.50
$8.33
AVG Volume (30 Days)
1.0M
4.0M
Earning Date
04-30-2026
05-13-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$452,956,000.00
$230,981,000.00
Revenue This Year
$14.38
$1,115.92
Revenue Next Year
$19.12
$81.04
P/E Ratio
N/A
N/A
Revenue Growth
12.74
N/A
52 Week Low
$17.80
$1.57
52 Week High
$74.60
$6.04

Technical Indicators

Market Signals
Indicator
COHU
PGEN
Relative Strength Index (RSI) 38.08 58.35
Support Level $43.64 $3.96
Resistance Level $52.43 $6.04
Average True Range (ATR) 3.54 0.28
MACD -0.88 -0.01
Stochastic Oscillator 6.42 82.95

Price Performance

Historical Comparison
COHU
PGEN

About COHU Cohu Inc.

Cohu Inc is a supplier of semiconductor test and inspection handlers, micro-electro-mechanical system (MEMS) test modules, test contactors, and thermal sub-systems used by semiconductor manufacturers and test subcontractors. The company's products include Semiconductor ATE (Automated Test Equipment), Semiconductor Handlers, Interface Products such as test contactors, probe heads, and probe pins, Spares and Kits, Bare Board PCB Test Systems, and services. It has one reportable segment, Semiconductor Test and Inspection Equipment (Semiconductor Test & Inspection). Geographically, the company generates maximum revenue from the Philippines, followed by Taiwan, China, Malaysia, the United States, Singapore, and the Rest of the world.

About PGEN Precigen Inc.

Precigen Inc is a commercial-stage biopharmaceutical company focused on developing precision medicines to improve the lives of patients, targeting immuno-oncology, autoimmune disorders, and infectious diseases using its proprietary and complementary technology platforms. These platforms support the development of gene programs, delivery through viral, non-viral, and microbe-based approaches, and control of gene expression for safety and efficacy. Its key platforms include AdenoVerse immunotherapy and UltraCAR-T, supported by the UltraPorator device for rapid and cost-effective manufacturing. Its clinical pipeline includes PRGN-2009, PRGN-3005, PRGN-3006, and PRGN-3007. Its reportable segments are Biopharmaceuticals and Exemplar.

Share on Social Networks: